GeneDx Holdings Corp. (WGS) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$14.36M; Operating income (m); Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA -$54.77M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA -$11.46M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA -$881,000.00; Operating income (m); Depreciation and amortization (m).
Complete source-backed ebitda history.
- Available history
- 2019-12-31 to 2026-06-30
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$14.36M | (m) | (m) | (m) | -12.54% | $10.11M* | -$28.98M* | $36.20M | $19.66M | $76.04M | -$518.00K |
|---|
| 2026-03-31 | Reported | -$54.77M | (m) | (m) | (m) | -53.56% | $6.45M | -$32.41M | $34.04M | $19.80M | $74.59M | $897.00K |
|---|
| 2025-12-31 | Reported | -$11.46M | (m) | (m) | (m) | -9.47% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | -$881,000.00 | (m) | (m) | (m) | -0.75% | $6.17M* | $15.77M* | $32.22M | $19.83M | (m) | $247.00K |
|---|
| 2025-06-30 | Reported | $11.26M | (m) | (m) | (m) | 10.96% | $2.37M* | $10.42M* | $31.79M | $15.08M | $46.86M | -$246.00K |
|---|
| 2025-03-31 | Reported | -$2.35M | (m) | (m) | (m) | -2.70% | $6.13M | $10.18M | $28.64M | $12.58M | $50.45M | $447.00K |
|---|
| 2024-12-31 | Reported | $10.83M | (m) | (m) | (m) | 11.32% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | -$5.36M | (m) | (m) | (m) | -6.97% | $646.00K* | -$4.39M* | $29.05M | $11.66M | (m) | -$47.00K |
|---|
| 2024-06-30 | Reported | -$8.87M | (m) | (m) | (m) | -12.57% | $1.35M* | -$4.50M* | $27.56M | $10.90M | (m) | -$190.00K |
|---|
| 2024-03-31 | Reported | -$11.92M | (m) | (m) | (m) | -19.09% | $443.00K | -$16.41M | $25.01M | $11.57M | (m) | -$82.00K |
|---|
| 2023-12-31 | Reported | -$23.07M | (m) | (m) | (m) | -40.17% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2023-09-30 | Reported | -$37.8M | (m) | (m) | (m) | -70.92% | $112.00K* | -$41.23M* | $28.04M | $14.29M | (m) | -$172.00K |
|---|
| 2023-06-30 | Reported | -$44.8M | (m) | (m) | (m) | -91.97% | $2.76M* | -$53.50M* | $29.95M | $17.14M | (m) | -$196.00K |
|---|
| 2023-03-31 | Reported | -$55.23M | (m) | (m) | (m) | -128.04% | $0.00 | -$55.56M | $27.90M | $14.59M | (m) | -$147.00K |
|---|
| 2022-12-31 | Reported | -$294.31M | (m) | (m) | (m) | -479.72% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2022-09-30 | Reported | -$83.82M | (m) | (m) | (m) | -100.71% | $2.24M* | -$88.36M* | $69.69M | $13.35M | (m) | -$65.00K |
|---|
| 2022-06-30 | Reported | -$156.02M | (m) | (m) | (m) | -431.37% | $1.37M* | -$84.64M* | $65.77M | $27.17M | (m) | -$49.08M |
|---|
| 2022-03-31 | Reported | -$83.5M | (m) | (m) | (m) | -154.80% | $1.38M | -$81.49M | $48.32M | $21.32M | (m) | $0.00 |
|---|
| 2021-12-31 | Reported | -$109.99M | (m) | (m) | (m) | -190.28% | (m) | (m) | $60.61M | $22.25M | (m) | (m) |
|---|
| 2021-09-30 | Reported | -$82.77M | (m) | (m) | (m) | -191.70% | $1.02M* | -$70.94M* | $51.49M | $17.83M | (m) | $0.00 |
|---|
| 2021-06-30 | Reported | -$39.83M | (m) | (m) | (m) | -84.72% | $1.25M* | -$25.30M* | $48.18M | $11.95M | (m) | $0.00 |
|---|
| 2021-03-31 | Reported | -$191.76M | (m) | (m) | (m) | -298.68% | $2.08M | -$42.21M | $68.52M | $53.13M | (m) | $0.00 |
|---|
| 2020-12-31 | Reported | -$121.46M | (m) | (m) | (m) | -189.91% | (m) | -$20.30K* | $69.63M | $31.16M | (m) | (m) |
|---|
| 2020-09-30 | Reported | -$52.95M | (m) | (m) | (m) | -137.14% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2020-06-30 | Reported | (m) | -$34.16M | (m) | $30.10M | (m) | (m) | (m) | $34.51M | $9.36M | (m) | (m) |
|---|
| 2020-03-31 | Reported | (m) | -$26.77M | (m) | $46.66M | (m) | (m) | (m) | $37.14M | $13.10M | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | -$3.48M | (m) | (m) | (m) | -0.81% | $19.02M | $33.28M | $129.37M | $72.03M | (m) | -$116.00K |
|---|
| 2024-12-31 | Reported | -$15.31M | (m) | (m) | (m) | -5.01% | $5.49M | -$28.50M | $111.05M | $45.72M | (m) | -$343.00K |
|---|
| 2023-12-31 | Reported | -$160.9M | (m) | (m) | (m) | -79.43% | $5.25M | -$180.15M | $112.56M | $58.27M | (m) | -$926.00K |
|---|
| 2022-12-31 | Reported | -$617.65M | (m) | (m) | (m) | -263.17% | $7.16M | -$319.15M | $261.44M | $86.20M | (m) | -$49.05M |
|---|
| 2022-09-30 | Rolling | (m) | -$458.55M* | (m) | $231.15M* | (m) | (m) | (m) | $244.38M* | $84.08M* | (m) | (m) |
|---|
| 2022-06-30 | Rolling | (m) | -$456.00M* | (m) | $191.09M* | (m) | (m) | (m) | $226.18M* | $88.56M* | (m) | (m) |
|---|
| 2022-03-31 | Rolling | (m) | -$338.80M* | (m) | $201.94M* | (m) | (m) | (m) | $208.59M* | $73.34M* | (m) | (m) |
|---|
| 2021-12-31 | Reported | -$424.34M | (m) | (m) | (m) | -199.98% | $9.40M | -$190.43M | $228.80M | $105.16M | (m) | $0.00 |
|---|
| 2021-12-31 | Rolling | (m) | -$446.15M* | (m) | $212.19M* | (m) | (m) | (m) | $228.80M* | $105.16M* | (m) | (m) |
|---|
| 2021-09-30 | Rolling | (m) | -$455.41M* | (m) | $218.35M* | (m) | (m) | -$138.47M* | $237.82M* | $114.08M* | (m) | (m) |
|---|
| 2020-12-31 | Reported | -$230.26M | (m) | (m) | (m) | -128.41% | $24.09M | -$93.13M | $175.30M | $72.70M | (m) | $0.00 |
|---|
| 2019-12-31 | Reported | -$24.01M | (m) | (m) | (m) | -12.24% | $11.92M | -$18.73M | $113.39M | $34.91M | (m) | $0.00 |
|---|